Association of P2Y2 receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients

Purinergic Signalling

Volumn 9, Issue 1, 2013, Pages 41-49

  Wesselius, Anke ^a   Bours, Martijn J L ^a   Henriksen, Zanne ^b   Syberg, Susanne ^b   Petersen, Solveig ^b   Schwarz, Peter ^b   Jørgensen, Niklas R ^b   van Helden, Svenhjalmar ^c   Dagnelie, Pieter C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; Osteoporosis; Polymorphisms

Indexed keywords

PURINERGIC P2Y2 RECEPTOR;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; COHORT ANALYSIS; DNA EXTRACTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OSTEOPENIA; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; WRIST FRACTURE;

EID: 84873749314     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9326-3     Document Type: Article

References (23)

1. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2): S3-S7. doi: 10. 1007/s00198-004-1702-6.
2. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6): 581-589. doi: 10. 1007/s00198-004-1780-5.
3. Parfitt AM (1982) The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res 4(1): 1-6.
4. Orriss IR, Burnstock G, Arnett TR (2010) Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10(3): 322-330.
5. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds) In. Cell membrane receptors for drugs and hormones. Raven, New York, pp 107-118.
6. rAbbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64(3): 445-475.
7. Wesselius A, Bours MJ, Agrawal A, Gartland A, Dagnelie PC, Schwarz P, Jorgensen NR (2011) Role of purinergic receptor polymorphisms in human bone. Front Biosci 17: 2572-2585.
8. Lustig KD, Shiau AK, Brake AJ, Julius D (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 90(11): 5113-5117.
9. James G, Butt AM (2002) P2Y and P2X purinoceptor mediated Ca(2+) signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447(2-3): 247-260.
10. Bowler WB, Birch MA, Gallagher JA, Bilbe G (1995) Identification and cloning of human P2U purinocepter present in osteoclastoma, bone and osteoblasts. J Bone Miner Res 10(7): 1137-1145.
11. Jorgensen NR, Henriksen Z, Brot C, Eriksen EF, Sorensen OH, Civitelli R, Steinberg TH (2000) Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms. J Bone Miner Res 15(6): 1024-1032.
12. Maier R, Glatz A, Mosbacher J, Bilbe G (1997) Cloning of P2Y6 cDNAs and identification of a pseudogene: comparison of P2Y receptor subtype expression in bone and brain tissues. Biochem Biophys Res Commun 240(2): 298-302.
13. Hoebertz A, Mahendran S, Burnstock G, Arnett TR (2002) ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling. J Cell Biochem 86(3): 413-419.
14. Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR (2006) Osteoblast responses to nucleotides increase during differentiation. Bone 39(2): 300-309. doi: 10. 1016/j. bone. 2006. 02. 063.
15. 2 receptors and pyrophosphate. Endocrinology 148(9): 4208-4216.
16. Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR (2006) Osteoblast responses to nucleotides increase during differentiation. Bone 39: 300-309.
17. Katz S, Ayala V, Santillan G, Boland R (2011) Activation of the PI3K/Akt signaling pathway through P2Y(2) receptors by extracellular ATP is involved in osteoblastic cell proliferation. Arch Biochem Biophys 513 (2): 144-152. doi: 10. 1016/j. abb. 2011. 06. 013.
18. Zhang Y, Zhang L, Yan M, Zheng X (2007) Inhibition of phosphatidylinositol 3-kinase causes cell death in rat osteoblasts through inactivation of Akt. Biomed Pharmacother 61(5): 277-284. doi: 10. 1016/j. biopha. 2007. 02. 014.
19. Janssens R, Paindavoine P, Parmentier M, Boeynaems JM (1999) Human P2Y2 receptor polymorphism: identification and pharmacological characterization of two allelic variants. Br J Pharmacol 127(3): 709-716.
20. 2+ influx. Pharmacogenet Genom 16: 199-205.
21. van Helden S, Cauberg E, Geusens P, Winkes B, van der Weijden T, Brink P (2007) The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline. J Eval Clin Pract 13(5): 801-805. doi: 10. 1111/j. 1365-2753. 2007. 00784. x.
22. Henriksen Z (2011) The Arg312Ser single nucleotide polymorphism in the P2Y2 receptor gene is associated with postmenopausal rate of bone loss. Am Soc Bone Min Res 24: 1.
23. Duncan EL, Danoy P, Kemp JP, Leo PJ, McCloskey E, Nicholson GC, Eastell R, Prince RL, Eisman JA, Jones G, Sambrook PN, Reid IR, Dennison EM, Wark J, Richards JB, Uitterlinden AG, Spector TD, Esapa C, Cox RD, Brown SD, Thakker RV, Addison KA, Bradbury LA, Center JR, Cooper C, Cremin C, Estrada K, Felsenberg D, Gluer CC, Hadler J, Henry MJ, Hofman A, Kotowicz MA, Makovey J, Nguyen SC, Nguyen TV, Pasco JA, Pryce K, Reid DM, Rivadeneira F, Roux C, Stefansson K, Styrkarsdottir U, Thorleifsson G, Tichawangana R, Evans DM, Brown MA (2011) Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 7 (4): e1001372. doi: 10. 1371/journal. pgen. 1001372.